Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion. - Abstract - Europe PMC
Thoracic Ultrasound | PDF | Wavelength | Waves
Myeloid-derived interleukin-1β drives oncogenic KRAS -NF-κΒ addiction in malignant pleural effusion | Nature Communications
PDF) Video-assisted thoracoscopic iodopovidone pleurodesis for malignant pleural effusions in moderate to high-risk Colombian patients
Ioannis Psallidas, CISSP, CISA, CRISC, COBIT5F - Director-Assurance of Infrastructures and Privacy of Services and Internet Applications Division - Hellenic Authority for Communication Security and Privacy | LinkedIn
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion. - Abstract - Europe PMC
PDF) The management of benign non-infective pleural effusions
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory - Page 3
Osteopontin is upregulated in malignant and inflammatory pleural effusions - MOSCHOS - 2009 - Respirology - Wiley Online Library
Ioannis Psallidas | hosco.
Table of Contents — August 01, 2019, 54 (2) | European Respiratory Society
PDF) Diagnostic Value and Prognostic Significance of Pleural C-Reactive Protein in Lung Cancer Patients with Malignant Pleural Effusions
Ioannis Psallidas, MD, PhD, FCCP, Associate Professor - Global Clinical Head, Respiratory & Immunology - AstraZeneca | LinkedIn
ERS International Congress 2017 - Program by Margaritidis Audio Visual - issuu
ROC comparison of OPN level measurements in the diagnostic groups and... | Download Scientific Diagram
Observation of a new excited beauty strange baryon decaying to $\Xi_{\mathrm{b}}^{-}\pi^{+}\pi^{-}$ - CERN Document Server
Supplemental Materials for Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis - The Lancet Oncology
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
HELP SHAPE THE FUTURE OF RESPIRATORY SCIENCE AND MEDICINE CONGRESS GUIDE - PDF Free Download
PDF) Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual ...
Malignant pleural effusion: from bench to bedside.” Ioannis Psallidas, Ioannis Kalomenidis, Jose M. Porcel, Bruce W. Robinson and Georgios T. Stathopoulos. Eur Respir Rev 2016; 25: 189–198. | European Respiratory Society
